Dengue fever in children: Where are we now?

Pediatric Infectious Disease Journal

Volumn 32, Issue 9, 2013, Pages 1020-1022

  Elling, Roland ^a   Henneke, Philipp ^a   Hatz, Christoph ^b   Hufnagel, Markus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; CHEMOPROPHYLAXIS; CHILDHOOD DISEASE; CLINICAL FEATURE; DENGUE; EPIDEMIOLOGY; HUMAN; INFECTION PREVENTION; PRIORITY JOURNAL; REVIEW; VIRUS DIAGNOSIS; VIRUS PATHOGENESIS;

CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DENGUE; HUMANS; INFANT;

EID: 84891605827     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829fd0e9     Document Type: Review

References (9)

1. World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control - New Edition. Geneva: World Health Organization; 2009.
2. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496:504-507.
3. De Souza LJ, Bastos Pessanha L, Carvalho Mansur L, et al. Comparison of clinical and laboratory characteristics between children and adults with dengue. Braz J Infect Dis. 2013;17:27-31.
4. Zompi S, Harris E. Animal models of dengue virus infection. Viruses. 2012;4:62-82.
5. Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011;11:532-543.
6. Horstick O, Farrar J, Lum L, et al. Reviewing the development, evidence base, and application of the revised dengue case classification. Pathog Glob Health. 2012;106:94-101.
7. Simmons CP, Farrar JJ, Nguyen VV, et al. Dengue. N Engl J Med. 2012;366:1423-1432.
8. Nguyen NM, Tran CN, Phung LK, et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis. 2013;207:1442-1450.
9. Sabchareon A, Wallace D, Sirivichayakul C, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. 2012;380:1559-1567.